Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION?

MLA

Galper, Benjamin Z., et al. “Cost-Effectiveness of TAVR in Low-Risk Patients: Do We Have More than a NOTION?” EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol. 15, no. 11, Dec. 2019, pp. e953–55. EBSCOhost, https://doi.org/10.4244/EIJV15I11A179.

APA

Galper, B. Z., Baron, S. J., & Cohen, D. J. (2019). Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION? EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 15(11), e953–e955. https://doi.org/10.4244/EIJV15I11A179

Chicago

Galper, Benjamin Z, Suzanne J Baron, and David J Cohen. 2019. “Cost-Effectiveness of TAVR in Low-Risk Patients: Do We Have More than a NOTION?” EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 15 (11): e953–55. doi:10.4244/EIJV15I11A179.